South Africa

Announcing Spider Impact V5 — Adapt and Achieve Your Strategy!

WASHINGTON, Oct. 20, 2021 /PRNewswire/ — Solidifying its commitment to enabling organizations to rapidly adapt and execute business strategy in the midst of unprecedented, ongoing market changes, Spider Strategies today introduced Spider Impact®, Version 5. Spider Impact is Spider Strategies’ Software-as-a-Service solution that aligns organization’s key performance indicators (KPIs) and initiatives to strategy, engages employees in […]

Huawei Kevin Hu: Intelligent Cloud-Network Inspires New Growth

DUBAI, UAE, Oct. 19, 2021 /PRNewswire/ — At the 7th Ultra-Broadband Forum (UBBF 2021), Kevin Hu, President of Huawei’s Data Communication Product Line, introduced four new features of Huawei’s Intelligent Cloud-Network Solution and all-scenario NetEngine series intelligent routers, providing differentiated cloud-network convergence service capabilities and accelerating digital transformation for industries. Digitalization has become a global development trend, […]

UBBF 2021: Network Infrastructure Construction Fuels Industry Development — A New Consensus

DUBAI, UAE, Oct. 19, 2021 /PRNewswire/ — The 7th Ultra-Broadband Forum (UBBF 2021), jointly hosted by the UN Broadband Commission and Huawei, officially opened today in Dubai. As the world’s largest summit in the fixed network field, this year’s UBBF focuses on the theme “Extend Connectivity, Drive Growth”. At the event, leading global operators and […]

Adagio Therapeutics Announces New In Vitro Data Highlighting Broad and Potent Neutralization of ADG20 Against All Known SARS-CoV-2 Variants

Data to be presented at the 2021 ISIRV-WHO Virtual Conference WALTHAM, Mass., Oct. 19, 2021 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc., (Nasdaq: ADGI) a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential, today announced new in vitro data demonstrating retained neutralizing activity of its monoclonal antibody […]